From the 2012 AACR Meeting – Systemic Inflammation and Survival in Men with Prostate Cancer: Evidence from the Glasgow Inflammation Outcome Study.

I met with Dr. Kashif Shafique of the University of Glasgow who was the senior author of a research poster presented at the meeting. He and his colleagues look at the relationship between systemic inflammation and prostate cancer survival. Since there is some evidence that pre-treatment of systemic inflammation in men may be associated with [...]

In Memory of Fred Gersh

This month has been very tough for the prostate cancer community. Earlier, prostate cancer took from us John Arnold who was both a consummate educator about prostate cancer and now it has taken another prostate cancer fighter, Fred Gersh. Fred passed away in the morning of April 6 after having been hospitalized for about [...]

A New Controversy Surrounding Provenge Continues To Complicate The Decision To Use It

According to an article written by Reuters some doctors have raised doubts about the efficacy of Provenge, known scientifically as sipuleucel-T. Prostate cancer vaccine Provenge has long incited passions unlike any other cancer therapy and the story seems to continue even to today. The current issue has been raised by Marie Huber, a trained scientist [...]

Being A True Strong Man When Dealing With Prostate Cancer

It is important to remember that confronting our feelings and giving them appropriate expression always takes strength, not weakness. It takes strength to acknowledge our anger, and sometimes more strength to curb the aggressive urges that our anger may bring and then to channel them into nonviolent outlets. It takes strength to face our sadness [...]

In Memory of John Arnold, A True Saint of A Man

It is with great sorrow I must share the news of the death of John Arnold. John had been a long time contributor to the advanced prostate cancer support group. As he approach the end of his life and decided to enter into Hospice Care he, in his typical unselfish way, let us know that [...]

Go to Top